BRD4-TARGETED THERAPY ABBV-744 CLINICAL DATA NO FURTHER A MYSTERY

These side effects had been notably milder in comparison with an inhibitor of both of those bromodomains. A detailed molecular analysis also discovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor- "Our study discovered the very important job of the KLF16/MYC regulatory axis in